RCE recce pharmaceuticals ltd

Recce Pharmaceuticals (RCE) has been awarded a rebate on almost...

  1. 7,926 Posts.
    lightbulb Created with Sketch. 1230
    • Recce Pharmaceuticals (RCE) has been awarded a rebate on almost $10 million of research and development (R&D) by AusIndustry
    • The award is a big win for Recce as the R&D rebates typically only apply to work done domestically
    • The new finding means the company can claim around $11.65 million in rebates for research it's conducting overseasAfter a recent $27.95 million capital raise, the additional rebate funds will provide the company with a substantial funding runway
    • The company is planning a number of trials for its suite of synthetic antiviral compounds to fight antibiotic-resistant superbugs and emerging viral pathogens
    • Recce Pharmaceuticals is up 0.83 per cent and trading at $1.22

    Read the full article on The Market Herald here.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
39.0¢
Change
0.005(1.30%)
Mkt cap ! $112.0M
Open High Low Value Volume
38.5¢ 39.0¢ 38.0¢ $279 729

Buyers (Bids)

No. Vol. Price($)
2 5005 38.5¢
 

Sellers (Offers)

Price($) Vol. No.
39.0¢ 49842 1
View Market Depth
Last trade - 14.39pm 31/07/2025 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.